-
New Study to Explore Real-World Impact of Inbrija® on Parkinson’s OFF Episodes
A new multi-country study will examine how people with Parkinson’s disease experience OFF episodes and how treatment with Inbrija® affects their daily lives and quality of life. The research aims to better capture the real-world patient perspective on this inhaled therapy.
-
Exploring Clinical Trials: A Pathway to Accessing Investigational Peptide Retatrutide
Retatrutide, a promising investigational peptide being studied for weight management, may be accessible to eligible participants through ongoing clinical trials. Here’s what interested individuals should know about this research pathway.
-
Mazdutide Shows Promising Results for Weight and Waist Reduction in Major Trial
A large clinical trial found that the peptide-based obesity drug mazdutide significantly reduced both body weight and waist circumference in participants, offering new hope for metabolic health management.
-
Path to Prescription: Popular Peptides May Gain Formal FDA-Backed Access
Peptides currently sold online without oversight may soon become available through legitimate prescription channels, a shift that could improve safety and consistency for patients seeking these therapies.
-
Understanding Peptide Therapy: A Guide to FDA-Approved Options and Their Benefits
A new overview highlights the growing landscape of peptide therapies, spotlighting which options have earned FDA approval and how they’re being used to support various aspects of health and wellness.
-
New Clinical Trial Explores Adding Durvalumab to Chemotherapy for Upper Urinary Tract Cancer
A phase II/III trial is investigating whether combining the immunotherapy durvalumab with standard chemotherapy before surgery could improve outcomes for patients with high-grade upper urinary tract cancer.
-
New Clinical Trial Explores Glofitamab as a Promising Option for Relapsed Mantle Cell Lymphoma
A new study is comparing glofitamab monotherapy to standard treatment combinations in patients with relapsed or refractory mantle cell lymphoma, offering hope for improved options in this challenging cancer.
-
New Clinical Trial Explores Nivolumab Plus Chemotherapy for Nasopharyngeal Carcinoma
A phase II trial is investigating whether combining the immunotherapy nivolumab with chemotherapy before radiation can improve outcomes for patients with nasopharyngeal carcinoma, while potentially reducing radiation exposure in children.
-
New Clinical Trial Explores Targeted Radioactive Therapy for Rare Thyroid Cancer
A new NIH-sponsored trial is testing 177Lu-DOTA-EB-TATE, a targeted radioactive peptide drug, in patients with treatment-resistant Hurthle cell thyroid cancer that has spread and no longer responds to standard radioactive iodine therapy.
-
New Clinical Trial Explores How Collagen Peptides May Help Knee Osteoarthritis
A new double-blind study in Türkiye will compare two collagen peptide formulations against placebo to see how they affect pain, function, and quality of life in adults with knee osteoarthritis.